What one share of Sanara Medtech holds
Our products, services and technologies are designed to achieve our goal of providing better clinical outcomes
Sanara Medtech’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $12.63 |
|---|---|
| Profit | −$3.68 |
| Capex (buildings and equipment) | $0.14 |
| Free cash flow | $0.52 |
| Cash and investments | $1.68 |
| Debt | $5.06 |
| Book value | $0.86 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2010 | $2.54 | −$18.54 | — | — | — | $1.35 |
| 2011 | $4.04 | −$23.29 | — | — | — | −$6.57 |
| 2012 | $1.87 | −$2.94 | — | — | — | −$5.53 |
| 2013 | $2.22 | −$5.00 | $0.04 | −$2.38 | — | −$2.88 |
| 2014 | $2.99 | −$3.00 | $0.01 | −$1.93 | — | −$0.89 |
| 2018 | $2.69 | $0.00 | $0.00 | $0.12 | — | $0.25 |
| 2019 | $5.52 | −$1.32 | $0.09 | −$1.10 | — | $1.85 |
| 2020 | $2.72 | −$0.76 | $0.09 | −$0.80 | — | $0.98 |
| 2021 | $3.29 | −$1.08 | $0.02 | −$0.68 | — | $3.99 |
| 2022 | $5.80 | −$1.00 | $0.02 | −$0.72 | — | $5.04 |
| 2023 | $7.85 | −$0.52 | $0.03 | −$0.42 | — | $5.25 |
| 2024 | $10.22 | −$1.14 | $0.02 | −$0.03 | — | $4.50 |
| 2025 | $11.96 | −$4.36 | $0.54 | $0.25 | — | $0.66 |
Common questions about Sanara Medtech
How much does one share of Sanara Medtech earn?
Over the last 12 months, Sanara Medtech lost $3.68 for each share on $12.63 of sales.
Does Sanara Medtech pay a dividend?
Sanara Medtech didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Sanara Medtech’s book value per share?
Sanara Medtech’s book value is $0.86 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Sanara Medtech have?
Each share of Sanara Medtech has $1.68 of cash and investments and $5.06 of debt, as of June 30, 2026.
What is Sanara Medtech’s free cash flow per share?
$0.52 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Sanara Medtech bought back shares?
Sanara Medtech’s share count rose about 2307% from 2010 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.